brand newYou can now listen to Fox News articles! With millions of people using injectable GLP-1 drugs like Ozempic, Wegovy or Zepbound, many may wonder what happens if they stop. Previous clinical trials have suggested an encouraging “recovery” effect, where patients regain a significant portion of their lost weight immediately after treatment ends. However, a … Read more
Drugs such as semaglutide (Ozempac, Vigovi) and terzapatide (Monjaro, Zipbound) have changed the landscape of weight management, offering hope where traditional methods have stalled. Both drugs work by mimicking gut hormones that regulate insulin release, slow digestion and reduce appetite, with the overall effect of making you feel fuller faster and for longer. Many patients … Read more
One study found that 55% of obese people regained the weight they lost after stopping GLP-1 medication, and so did 45% of diabetics. It also found that 45% of obese participants and 56% of diabetics lost weight or kept it off while off the medication. However, many of those who had successful outcomes still received … Read more